Britannia Life Sciences Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr '25 Apr 25, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Market Capitalization	10	11	15	31	-	-
Market Cap Growth	6.67%	-26.32%	-49.89%	-	-	-
Enterprise Value	21	21	25	38	-	-
Last Close Price	0.06	0.07	0.10	0.19	-	-
PE Ratio	-	-	3.03	-	-	-
PS Ratio	1.35	1.50	2.41	4.21	-	-
PB Ratio	1.67	1.70	1.39	5.61	-	-
P/FCF Ratio	8.96	5.80	7.89	11.34	-	-
P/OCF Ratio	8.73	5.43	7.68	10.99	-	-
EV/Sales Ratio	2.85	2.76	3.90	5.26	-	-
EV/EBITDA Ratio	-	14.82	22.64	21.88	-	-
EV/EBIT Ratio	-	16.24	25.15	23.75	-	-
EV/FCF Ratio	18.88	10.68	12.80	14.15	-	-
Debt / Equity Ratio	1.22	1.09	0.76	0.95	3.96	-
Debt / EBITDA Ratio	7.14	4.80	7.31	2.88	32.63	-
Debt / FCF Ratio	6.54	3.72	4.31	1.92	-	-
Asset Turnover	0.32	0.33	0.29	0.34	0.13	-
Quick Ratio	0.18	0.24	0.91	0.41	0.25	1.03
Current Ratio	0.20	0.26	0.92	0.42	0.25	1.03
Return on Equity (ROE)	-83.66%	-49.61%	70.57%	-343.40%	10.72%	-
Return on Assets (ROA)	2.47%	3.51%	2.78%	4.75%	1.67%	-
Return on Capital (ROIC)	3.46%	4.81%	4.12%	8.46%	2.73%	-
Return on Capital Employed (ROCE)	8.50%	10.90%	5.20%	12.70%	2.60%	-
Earnings Yield	-81.96%	-41.98%	32.98%	-50.26%	-	-
FCF Yield	11.16%	17.23%	12.67%	8.82%	-	-
Buyback Yield / Dilution	0.05%	-0.07%	-48.07%	-41.06%	-1138.06%	-

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.